Drug intelligence / Profile preview

ibuprofen + pregabalin + acetaminophen + tizanidine

Development stage
Unknown
Lead developer
Henry Ford Health
Modality
Small Molecules
Administration
Oral
01

Overview

This multimodal non-opioid pain management regimen, studied by the Henry Ford Health System, consists of a combination of four medications: ibuprofen, pregabalin, acetaminophen, and tizanidine. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes to reduce inflammation and pain. Pregabalin is a gabapentinoid that binds to the alpha-2-delta subunit of voltage-gated calcium channels, modulating the release of excitatory neurotransmitters to treat neuropathic and acute pain. Acetaminophen provides analgesic and antipyretic effects through central mechanisms, while tizanidine acts as a centrally acting alpha-2 adrenergic agonist to reduce muscle spasticity and provide supplemental analgesia. This regimen is being evaluated in Phase 4 clinical trials as an alternative to standard opioid-based analgesia for patients undergoing orthopedic procedures, such as open reduction and internal fixation (ORIF) of clavicle fractures, to mitigate the risks associated with opioid use.

Other names
nonnarcotic pain medications-Henry Ford Health System-postoperative painNonopioid Pain Control RegimenMultimodal nonopioid regimen
02

Targets

α2δ (Voltage-gated calcium channel alpha-2-delta subunit)ADRA2A (α2A)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ibuprofen + pregabalin + acetaminophen + tizanidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + pregabalin + acetaminophen + tizanidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call